Nordic Bioscience

Advancing precision medicine through biomarker science

Herlev, Denmark · Founded 1996 · $100.0M raised

Headquarters
Herlev
Employees
51–200
Founded
1996
Business Model
B2B
Total Funding
$100.0M
Last Round
$100.0M Private EquityMar 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Nordic Bioscience is a Denmark-based, research-driven biomarker company specializing in the development and commercialization of extracellular matrix (ECM) biomarkers for pharmaceutical and diagnostics partners. Using its proprietary ProteinFingerPrint technology, the company measures specific protein fragments — particularly collagen and ECM degradation products — to support drug development across a wide range of disease areas including rheumatology, hepatic fibrosis, oncology, cardiovascular, respiratory, kidney, and neurological diseases. Nordic Bioscience offers laboratory services, kit-in-a-box biomarker products, and translational research models. It has contributed to over 750 scientific publications and counts major pharma companies among its partners. The company is headquartered in Herlev, Denmark, and was founded in 1996.

Summary

Nordic Bioscience is a Biotech company based in Herlev, Denmark, founded in 1996. It has raised $100.0M in total across 1 round, most recently a $100.0M Private Equity round in Mar 2021. Investors include KKR.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityMar 2021
$100.0M

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nordic Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/nordic-bioscience"><img src="https://indexed.vc/api/badge/company/nordic-bioscience" alt="Nordic Bioscience on Indexed.vc" width="260" height="76" /></a>